TITLE:
A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

CONDITION:
Cytomegalovirus Retinitis

INTERVENTION:
Nelfinavir mesylate

SUMMARY:

      The purpose of this study is to see if it is safe and effective to give Viracept to AIDS
      patients who are already being treated for cytomegalovirus (CMV) retinitis.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 13 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  HIV infection.

          -  Newly diagnosed or first progression of CMV retinitis.

        Exclusion Criteria

        Prior Medication:

        Excluded:

        Prior therapy (or less than 2 weeks) with protease inhibitor other than saquinavir.
      
